Although several common treatment options are currently used to care for patients diagnosed with COVID-19, the preferred treatment varies depending on age population. Recent data shows that older patients are more frequently prescribed Dexamethasone—and rate of usage increases as the patient age goes up. However, Azithromycin appears to be the treatment of choice for patients in younger age groups, with the highest rate of usage in patients ranging from 10 to 19 years old. Read our latest COVID-19 Trend Insights report for more details.
You may also be interested in:
News
COVID-19 Bi-Weekly Trend Insights
As the COVID-19 pandemic continues, researchers are starting to get a clearer picture of patient demographics. While a majority of early patients…
News
COVID-19 Bi-Weekly Trend Insights
The COVID-19 patient group continually studied by PRA serves as a baseline to understand the demographics of patients receiving the vaccine. Between…
News
COVID-19 Bi-Weekly Trend Insights
As the COVID-19 pandemic unfolds, it’s becoming increasingly clear that younger populations are not immune to the virus. Patients under the age of 30…